A detailed history of Strs Ohio transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Strs Ohio holds 12,100 shares of ENTA stock, worth $122,573. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,100
Previous 12,100 -0.0%
Holding current value
$122,573
Previous $156,000 19.87%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$11.43 - $17.02 $44,577 - $66,378
-3,900 Reduced 24.38%
12,100 $156,000
Q1 2024

May 13, 2024

SELL
$10.08 - $17.46 $27,216 - $47,142
-2,700 Reduced 14.44%
16,000 $279,000
Q4 2023

Jan 30, 2024

BUY
$8.18 - $10.78 $26,176 - $34,496
3,200 Added 20.65%
18,700 $175,000
Q2 2023

Jul 31, 2023

BUY
$20.68 - $39.85 $24,816 - $47,820
1,200 Added 8.39%
15,500 $331,000
Q1 2023

Aug 02, 2023

SELL
$38.82 - $54.59 $46,584 - $65,508
-1,200 Reduced 7.74%
14,300 $578,000
Q3 2022

Oct 27, 2022

SELL
$48.29 - $71.27 $28,974 - $42,762
-600 Reduced 4.03%
14,300 $741,000
Q2 2022

Jul 25, 2022

BUY
$38.13 - $76.93 $30,504 - $61,544
800 Added 5.67%
14,900 $704,000
Q4 2021

Jan 24, 2022

BUY
$60.19 - $97.37 $222,703 - $360,269
3,700 Added 35.58%
14,100 $1.05 Million
Q3 2021

Oct 22, 2021

SELL
$41.02 - $58.65 $188,692 - $269,790
-4,600 Reduced 30.67%
10,400 $590,000
Q2 2021

Jul 26, 2021

BUY
$43.76 - $53.11 $61,264 - $74,354
1,400 Added 10.29%
15,000 $660,000
Q2 2020

Jul 23, 2020

BUY
$46.37 - $57.58 $51,007 - $63,338
1,100 Added 8.8%
13,600 $682,000
Q4 2019

Jan 24, 2020

BUY
$57.95 - $66.61 $40,565 - $46,627
700 Added 5.93%
12,500 $772,000
Q3 2019

Oct 21, 2019

BUY
$60.08 - $88.17 $48,064 - $70,536
800 Added 7.27%
11,800 $708,000
Q2 2019

Jul 25, 2019

BUY
$81.3 - $97.35 $821,130 - $983,235
10,100 Added 1122.22%
11,000 $928,000
Q4 2018

Jan 23, 2019

SELL
$65.41 - $84.65 $699,887 - $905,755
-10,700 Reduced 92.24%
900 $63,000
Q3 2018

Oct 19, 2018

BUY
$85.46 - $126.37 $68,368 - $101,096
800 Added 7.41%
11,600 $991,000
Q2 2018

Aug 06, 2018

SELL
$81.85 - $120.51 $73,665 - $108,459
-900 Reduced 7.69%
10,800 $1.25 Million
Q1 2018

Apr 20, 2018

SELL
$57.91 - $92.15 $295,341 - $469,965
-5,100 Reduced 30.36%
11,700 $946,000
Q4 2017

Jan 23, 2018

SELL
$45.65 - $59.37 $31,955 - $41,559
-700 Reduced 4.0%
16,800 $985,000
Q3 2017

Oct 23, 2017

BUY
$37.91 - $46.8 $663,424 - $819,000
17,500
17,500 $819,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $210M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.